Tocilizumab for treatment of mechanically ventilated patients with COVID-19 EC Somers, GA Eschenauer, JP Troost, JL Golob, TN Gandhi, L Wang, ... Clinical Infectious Diseases 73 (2), e445-e454, 2021 | 510 | 2021 |
Comparison of echinocandin antifungals G Eschenauer, DD DePestel, PL Carver Therapeutics and clinical risk management 3 (1), 71-97, 2007 | 235 | 2007 |
Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients RK Shields, CJ Clancy, LM Gillis, EJ Kwak, FP Silveira, RCA Massih, ... PloS one 7 (12), e52349, 2012 | 157 | 2012 |
Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes M Nguyen, GA Eschenauer, M Bryan, K O'Neil, EY Furuya, P Della-Latta, ... Diagnostic microbiology and infectious disease 67 (2), 180-184, 2010 | 120 | 2010 |
Risk factors and outcomes associated with treatment of asymptomatic bacteriuria in hospitalized patients LA Petty, VM Vaughn, SA Flanders, AN Malani, A Conlon, KS Kaye, ... JAMA internal medicine 179 (11), 1519-1527, 2019 | 109 | 2019 |
Pharmacology and therapeutic uses of theanine G Eschenauer, BV Sweet American journal of health-system pharmacy 63 (1), 26-30, 2006 | 105 | 2006 |
Antifungal prophylaxis in liver transplant recipients GA Eschenauer, SW Lam, PL Carver Liver Transplantation 15 (8), 842-858, 2009 | 83 | 2009 |
Targeted versus universal antifungal prophylaxis among liver transplant recipients GA Eschenauer, EJ Kwak, A Humar, BA Potoski, LG Clarke, RK Shields, ... American journal of transplantation 15 (1), 180-189, 2015 | 81 | 2015 |
Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates GA Eschenauer, MH Nguyen, S Shoham, JA Vazquez, AJ Morris, ... Antimicrobial agents and chemotherapy 58 (4), 1897-1906, 2014 | 69 | 2014 |
Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne … A Espinel-Ingroff, M Alvarez-Fernandez, E Cantón, PL Carver, SCA Chen, ... Antimicrobial agents and chemotherapy 59 (11), 6725-6732, 2015 | 67 | 2015 |
A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia F Foolad, AM Huang, CT Nguyen, L Colyer, M Lim, J Grieger, J Li, ... Journal of Antimicrobial Chemotherapy 73 (5), 1402-1407, 2018 | 55 | 2018 |
Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study GA Eschenauer, PL Carver, SW Lin, KP Klinker, YC Chen, BA Potoski, ... Journal of Antimicrobial Chemotherapy 68 (4), 922-926, 2013 | 49 | 2013 |
Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study CT Nguyen, T Gandhi, C Chenoweth, J Lassiter, J Dela Pena, ... Journal of Antimicrobial Chemotherapy 70 (12), 3390-3396, 2015 | 47 | 2015 |
Evolving role of early antifungals in the adult intensive care unit SW Lam, GA Eschenauer, PL Carver Critical care medicine 37 (5), 1580-1593, 2009 | 39 | 2009 |
Antifungal prophylaxis in lung transplant recipients TS Patel, GA Eschenauer, LJ Stuckey, PL Carver Transplantation 100 (9), 1815-1826, 2016 | 38 | 2016 |
To Test or Not To Test: a Cost Minimization Analysis of Susceptibility Testing for Patients with Documented Candida glabrata Fungemias CD Collins, GA Eschenauer, SL Salo, DW Newton Journal of clinical microbiology 45 (6), 1884-1888, 2007 | 36 | 2007 |
Is fluconazole or an echinocandin the agent of choice for candidemia GA Eschenauer, MH Nguyen, CJ Clancy Annals of Pharmacotherapy 49 (9), 1068-1074, 2015 | 32 | 2015 |
The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infection M Kludze-Forson, GA Eschenauer, CJ Kubin, P Della-Latta, SW Lam Medical Mycology 48 (2), 436-439, 2010 | 31 | 2010 |
Doripenem MICs and ompK36 Porin Genotypes of Sequence Type 258, KPC-Producing Klebsiella pneumoniae May Predict Responses to Carbapenem-Colistin … RK Shields, MH Nguyen, BA Potoski, EG Press, L Chen, BN Kreiswirth, ... Antimicrobial agents and chemotherapy 59 (3), 1797-1801, 2015 | 27 | 2015 |
The evolving role of antifungal susceptibility testing GA Eschenauer, PL Carver Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (5 …, 2013 | 25 | 2013 |